Hydrochlorothiazide/Timolol Maleate

氢氯噻嗪/马来酸噻吗洛尔

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHydrochlorothiazide/Timolol Maleate
Drug Alias NameTimolol Maleate-Hydrochlorothiazide马来酸噻吗洛尔/氢氯噻嗪Timolol Maleate and HydrochlorothiazideHydrochlorothiazide and Timolol MaleateTimolol Maleate/Hydrochlorothiazide +[6] 
ClassificationSmall molecules
Mechanisms of ActionBeta adrenergic receptors antagonistsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterBeta adrenergic receptors
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1981/12/11
Country/TerritoryUnited States
CombinationsYes HydrochlorothiazideTimolol Maleate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC07BA06
Related LinksN/A